Plasma activity of contact coagulation factors in patients with IgA nephritis

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 2, 1996, Pages 218-221

  Tan, C C ^a,c   Lee, G S L ^b   Lee, E J C ^a   Woo, K T ^b  

^a National University Hospital

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Factor XII; Glomerular injury; High molecular weight kininogen; Intraglomerular coagulation; Prekallikrein

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 12; KALLIKREIN; KININOGEN;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PATHOPHYSIOLOGY; PROGNOSIS; REFERENCE VALUE;

ADULT; BLOOD COAGULATION FACTORS; FACTOR XII; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KALLIKREINS; KININOGENS; MALE; PROGNOSIS; REFERENCE VALUES;

EID: 0030098738     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Woo K T, Edmondson R P S, Wu A Y T, Chiang G S C, Pwee H S, Lim C H. The natural history of IgA nephritis in Singapore. Clin Nephrol 1986; 25 15-21.
2. 51Cr-EDTA clearance. Kidney Int 1991; 40:1050-4.
3. Clarkson A R, Woodroffe A J, AArons I. IgA nephropathy and Henoch-Schonlein purpura. In: Schrier R W, Gottschalk C W, editors. Diseases of the Kidney. Boston/Toronto Little, Brown and Co, 1989:2061-89.
4. Lai K N, Lai F M, Ho C P. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long term controlled trial. Clin Nephrol 1986; 26:174-80.
5. Clarkson A R, Seymour A E, Woodroffe A J. Controlled trial of phenytoin therapy in IgA. Clin Nephrol 1980; 13:215-21.
6. Tipping P G, Thomson N M, Holdsworth S R A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol 1986; 67:481-91.
7. Kincaid-Smith P. Coagulation and renal disease. Kidney Int 1972; 2:183-90.
8. Kamitsuji H, Kusumoto K, Taira K, Idda Y, Nakajima M, Fukui H. Localization of intrarenal cross-linked fibrin in children with various renal diseases. Nephron 1983; 35 94-9
9. Deguchi F, Tomuta S, Yoshiyama N, Takeuchi J Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases. Nephron 1989; 51:377-83.
10. Yamabe H, Sugawara N, Ozawa K, Kubota H, Fukushi K, Kikuchi K, et al. Glomerular deposition of Hageman factor in IgA nephropathy Nephron 1984; 37:62-3.
11. Hutton R A. Normal haemostasis In: Hoffbrand A V, Lewis S M, editors. Postgraduate Haematology. London: Heinemann Press, 1989:574-6.
12. Thompson A R. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients. Thromb Haemost 1982; 48:27-32.
13. Saito H, Goodnough L T, Maker S P, Kallen R J. Urinary excretion of Hageman factor (factor XII) and the presence of non-functional Hageman factor in the nephrotic syndrome. Am J Med 1981; 70:531-4.
14. Yoshioka K, Takemura T, Aya N, Akano N, Miyamoto H, Maki S. Monocyte infiltration and cross-linked fibrin deposition in IgA nephritis and Henoch-Schonlein purpura nephritis. Clin Nephrol 1989; 32:107-12.
15. Ono T, Kanatsu K, Doi T, Sekita K, Onoe C, Nagai H, et al. Relationship of intraglomerular coagulation and platelet aggregation to glomerular sclerosis. Nephron 1991; 58:429-36.
16. Woo K T, Tan Y O, Yap H K, Lau Y K, Lim C H. Beta-thromboglobulin in mesangial IgA nephritis. Thromb Res 1981; 24:259-62
17. Woo K T, Lee E J C, Lau Y K, Lim C H. Antithrombin III in mesangial IgA nephritis. Thromb Res 1985; 40:483-7.
18. Fine L G. Preventing the progression of human renal disease: Have rational therapeutic principles emerged? Kidney Int 1988; 33:116-28.
19. Woo K T, Edmondson R P S, Yap H K, Wu A Y T, Chiang G S C, Lee E J C, et al. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 1987; 27:56-64.
20. Lee G S L, Woo K T, Lim C H. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment [letter]. Clin Nephrol 1989; 31:276.